Pneumology - Original Articles
6 August 2025
Early Access
Health-related quality of life based on the European Questionnaire 5D-5L utility score in patients with multidrug-resistant tuberculosis
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
150
Views
90
Downloads
Authors
Patients' health-related quality of life (HRQOL) is negatively impacted by multidrug-resistant tuberculosis (MDR-TB). The HRQOL of MDR-TB patients was assessed in this study using the European Questionnaire 5D-5L (EQ-5D-5L) utility score and HRQOL-related parameters. We conducted a case-control study at the Haji Hospital from June to December 2024. MDR-TB patients and drug-sensitive (DS-TB) patients were divided into case and control groups, respectively. The HRQOL utility score and depression levels were measured using the Indonesian EQ-5D-5L and Patient Health Questionnaire-9 (PHQ-9), respectively. This study included 84 TB patients, 36 and 48 of whom had MDR-TB and DS-TB, respectively. Patients with DR-TB had a significantly higher PHQ-9 score (7.55±5.97 vs. 4.69±4.21; p=0.047) than patients with DS-TB. When compared to the control group, the case's EQ-5D-5L and EQ Visual Analog Scale utility scores were considerably lower, at 0.86±0.11 and 69.30±16.65 (p=0.005) against 0.92±0.07 and 80.70±15.53 (p=0.002), respectively. The EQ-5D-5L utility score was considerably lower in DR-TB patients with depression and a history of TB treatment. In conclusion, the HRQOL of MDR-TB patients was low. Among MDR-TB patients, depression and TB treatment history were associated with quality of life. This study provides insight into the need for healthcare practitioners to evaluate patients' HRQOL, particularly for those with risk factors.
Altmetrics
Downloads
Download data is not yet available.
Citations
World Health Organization. Global Tuberculosis Report 2020. Available from: https://www.who.int/publications/i/item/9789240013131.
Soedarsono S, Mertaniasih NM, Kusmiati T, et al. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects. BMC Pulm Med 2021;21:360. DOI: https://doi.org/10.1186/s12890-021-01735-9
World Health Organization. WHO consolidated operational handbook on tuberculosis: module 4: treatment and care. 2025. Available from: https://www.who.int/publications/i/item/9789240108141.
Fuady A, Arifin B, Yunita F, et al. Stigma, depression, quality of life, and the need for psychosocial support among people with tuberculosis in Indonesia: a multi-site cross-sectional study. PLOS Global Public Health 2024;4:e0002489. DOI: https://doi.org/10.1371/journal.pgph.0002489
Kodical SP, Roy R, Shetty D, et al. Exploring factors influencing the health-related quality of life of tuberculosis patients: a WHOQOL-BREF-based study. 2024. Monaldi Arch Chest Dis 95:2913. DOI: https://doi.org/10.4081/monaldi.2024.2913
Izhar MD, Butar MB, Hidayati F, Ruwayda R. Predictors and health-related quality of life with short form-36 for multidrug-resistant tuberculosis patients in Jambi, Indonesia: a case-control study. Clin Epidemiol Glob Health 2021;12:100872. DOI: https://doi.org/10.1016/j.cegh.2021.100872
Araia ZZ, Mesfin AB, Mebrahtu AH, et al. Health-related quality of life in tuberculosis patients in Eritrea: comparison among drug-susceptible and rifampicin/multidrug-resistant tuberculosis patients. Patient Relat Outcome Meas 2021;12:205-12. DOI: https://doi.org/10.2147/PROM.S316337
Duarsa KH, Widhiartini IA, Aman IG. Quality of life profile on multidrug-resistant tuberculosis patient at Prof. Dr. I Goesti Ngoerah Gde Ngoerah General Hospital. Neurol Spinal Med Chir 2023;6:1-5.
Datta S, Gilman RH, Montoya R, et al. Quality of life, tuberculosis and treatment outcome; a case-control and nested cohort study. Eur Res J 2020;56:1900495. DOI: https://doi.org/10.1183/13993003.00495-2019
Venkatesh U, Sharma A, Srivastava DK, Durga R. Health-related quality of life of multidrug-resistant tuberculosis patients: a study of eastern Uttar Pradesh, India. Indian J Tuberc 2022;69:347-53. DOI: https://doi.org/10.1016/j.ijtb.2021.06.002
Bai G, Zhang J, Chen Y, et al. Health-related quality of life assessed by EQ-5D-5L and its determinants among Chinese adults. Front Public Health 2024;12:1383781. DOI: https://doi.org/10.3389/fpubh.2024.1383781
Purba FD, Hunfeld JAM, Iskandarsyah A, et al. Quality of life of the Indonesian general population: test-retest reliability and population norms of the EQ-5D-5L and WHOQOL-BREF. PLoS One 2018;13:e0197098. DOI: https://doi.org/10.1371/journal.pone.0197098
Dian CN, Effendy E, Amin MM. The alidation of Indonesian version of patient health questionnaire-9. Open Access Maced J Med Sci 2022;10:193-8. DOI: https://doi.org/10.3889/oamjms.2022.9293
EQ-5D-5L. EuroQol Available from: https://euroqol.org/information-and-support/euroqol-instruments/eq-5d-5l/.
Nurlaela S, Rahardjo S, Jayanti RD. Analysis of the quality of life of tuberculosis patients based on the SF-36 form (case study in Banyumas Regency). Indian J Tuberc 2024;71:225-8. DOI: https://doi.org/10.1016/j.ijtb.2024.03.003
Vyawahare C, Mukhida S, Khan S, et al. Assessment of risk factors associated with drug-resistant tuberculosis in pulmonary tuberculosis patients. Indian J Tuberc 2024;71:S44-51. DOI: https://doi.org/10.1016/j.ijtb.2023.07.007
Russikh A, Korotych O, Sereda Y, et al. Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study. Monaldi Arch Chest Dis 2021;91;1678 DOI: https://doi.org/10.4081/monaldi.2021.1678
Putra ON, Yulistiani Y, Soedarsono S, Subay S. Early efficacy of individual regimens containing bedaquiline in patients with drug-resistant tuberculosis. Asian Pac J Trop Med 2023;16:169-75. DOI: https://doi.org/10.4103/1995-7645.372289
Xi Y, Zhang W, Qiao RJ, Tang J. Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis. PLoS One 2022;17:e0270003. DOI: https://doi.org/10.1371/journal.pone.0270003
Soedarsono S, Mertaniasih NM, Kusmiati T, et al. Characteristics of previous tuberculosis treatment history in patients with treatment failure and the impact on acquired drug-resistant tuberculosis. Antibiotics 2023;12:598. DOI: https://doi.org/10.3390/antibiotics12030598
Chen Z, Liu Q, Song R, et al. The association of glycemic level and prevalence of tuberculosis: a meta-analysis. BMC Endocr Disord 2021;21:123. DOI: https://doi.org/10.1186/s12902-021-00779-6
Srinivasan G, Chaturvedi D, Verma D, et al. Prevalence of depression and anxiety among drug-resistant tuberculosis: a study in North India. Indian J Tuberc 2021;68:457-63. DOI: https://doi.org/10.1016/j.ijtb.2021.04.010
Apang O, Shringarpure K, Laxmeshwar C, et al. Screening and management of depression among patients on TB treatment in Papumpare district, Arunachal Pradesh, India. Indian J Tuberc 2024;71:S155-61. DOI: https://doi.org/10.1016/j.ijtb.2024.05.009
Louw J, Peltzer K, Naidoo P, et al. Quality of life among tuberculosis (TB), TB retreatment and/or TB-HIV co-infected primary public health care patients in three districts in South Africa. Health Qual Life Outcomes 2012;10:77. DOI: https://doi.org/10.1186/1477-7525-10-77
Jo Y, Gomes I, Shin H, et al. Health-related quality of life of inpatients and outpatients with TB in rural Malawi. Int J Tuberc Lung Dis 2020;24:1165-71. DOI: https://doi.org/10.5588/ijtld.20.0085
Pang Y, Liu R, Song Y, et al. High incidence of psychiatric disorders associated with cycloserine treatment of multidrug-resistant tuberculosis patients: a cohort study in Beijing, China. Infect Drug Resist 2022;15:3725-32. DOI: https://doi.org/10.2147/IDR.S369715
Mishra G, Alffenaar JW, Munje R, Khateeb S. Adverse drug reactions due to linezolid in the programmatic management of drug-resistant tuberculosis in India: a retrospective multicenter study. Indian J Tuberc 2024;71:S101-9. DOI: https://doi.org/10.1016/j.ijtb.2023.04.006
Sineke T, Evans D, Schnippel K, et al. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa. Health Qual Life Outcomes 2019;17:94. DOI: https://doi.org/10.1186/s12955-019-1155-4
Rodríguez M, Bustos YC, Encarnación M, et al. Evaluation of a modified short all oral treatment regimen for rifampicin-multidrug resistant tuberculosis in Dominican Republic. BMC Infect Dis 2025;25:196. DOI: https://doi.org/10.1186/s12879-024-10417-w
Amer M, Akhlaq M, Rafique M, et al. Health-related quality of life (HRQoL) in tuberculosis patients: a cross-sectional study using the EuroQoL EQ-5D-3L scale. SN Compr Clin Med 2023;5:53. DOI: https://doi.org/10.1007/s42399-023-01389-0
Park HY, Cheon H Bin, Choi SH, Kwon JW. Health-related quality of life based on EQ-5D utility score in patients with tuberculosis: a systematic review. Front Pharmacol 2021;12:659675. DOI: https://doi.org/10.3389/fphar.2021.659675
Paikray E, Pattnaik M, Mishra V, et al. Evaluation of health-related quality of life and adherence among pre-extensively drug-resistant tuberculosis patients receiving either Bedaquiline or Delamanid regimen at a teaching hospital in Eastern India. J Family Med Prim Care 2024;13:4684-92. DOI: https://doi.org/10.4103/jfmpc.jfmpc_572_24
Solanki N, Upadhyay A, Upadhyay R, et al. A cross-sectional study on the prevalence of depression and associated factors in tuberculosis patients in the Vidisha district of Madhya Pradesh, India. Cureus 2023; 15:e46637. DOI: https://doi.org/10.7759/cureus.46637
Walker IF, Khan AM, Khan AM, et al. Depression among multidrug-resistant tuberculosis patients in Punjab, Pakistan: a large cross-sectional study. Int J Tuberc Lung Dis 2018;22:773-8. DOI: https://doi.org/10.5588/ijtld.17.0788
Rouf A, Masoodi MA, Dar MM, et al. Depression among tuberculosis patients and its association with treatment outcomes in district Srinagar. J Clin Tuberc Other Mycobact Dis 2021;25:100281. DOI: https://doi.org/10.1016/j.jctube.2021.100281
Gare KP, Sebakeng M, Molefi M. The health-related quality of life of drug-resistant tuberculosis patients receiving treatment in Botswana. BMC Infect Dis 2024;24:1367. DOI: https://doi.org/10.1186/s12879-024-10258-7
Shen R, Zong K, Zhang L. Risk factors for depression in tuberculosis patients: a meta-analysis. Neuropsychiatr Dis Treat 2022;18:847-6. DOI: https://doi.org/10.2147/NDT.S347579
Ethics approval
This study was authorized by the Haji Hospital's ethical committee for health research with approval number 445/149/KOM.ETIK/2024.How to Cite
“Health-Related Quality of Life Based on the European Questionnaire 5D-5L Utility Score in Patients With Multidrug-Resistant Tuberculosis”. 2025. Monaldi Archives for Chest Disease, August. https://doi.org/10.4081/monaldi.2025.3450.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.